Heart rate elevation precedes the development of metabolic syndrome in Japanese men: A prospective study

Hypertension Research

Volumn 30, Issue 5, 2007, Pages 417-426

  Tomiyama, Hirofumi ^a   Yamada, Jiko ^a   Koji, Yutaka ^a   Yambe, Minoru ^a   Motobe, Kohki ^a   Shiina, Kazuki ^a   Yamamoto, Yoshio ^b   Yamashina, Akira ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b KAJIMA CORPORATION   (Japan)

Author keywords

Heart rate; Metabolic syndrome; Sympathetic nervous system

Indexed keywords

ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; HEART RATE; HUMAN; JAPAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PULSE WAVE; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; TACHYCARDIA;

ADULT; AGED; BLOOD PRESSURE; BODY MASS INDEX; COHORT STUDIES; DISEASE PROGRESSION; HEART RATE; HUMANS; JAPAN; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PULSATILE FLOW; ROC CURVE; SENSITIVITY AND SPECIFICITY; SYMPATHETIC NERVOUS SYSTEM;

EID: 34250756656     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.30.417     Document Type: Article

References (40)

1. Grundy SM: MetCbolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 2006; 47: 1093-1100.
2. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson PW: Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Off-spring Study. Diabetes 2005; 54: 3252-3257.
3. Lim HS, Lip GY, Beevers DG, Blann AD: Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension. Eur J Clin Invest 2005; 35: 324-326.
4. Carnethon MR, Loria CM, Hill JO, Sidney S, Savage PJ, Liu K: Coronary Artery Risk Development in Young Adults study. Risk factors for the metabolic syndrome: The Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985-2001. Diabetes Care 2004; 27: 2707-2715.
5. McMillen IC, Robinson JS: Developmental origins of the metabolic syndrome: Prediction, plasticity, and programming. Physiol Rev 2005; 85: 571-633.
6. Grassi G, Seravalle G: Autonomic imbalance and metabolic syndrome: unravelling interactions, mechanisms and outcomes. J Hypertens 2006; 24: 47-49.
7. Reaven GM, Lithell H, Landsberg L: Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334: 374-381.
8. Brook RD, Julius S: Autonomic imbalance, hypertension, and cardiovascular risk. Am J Hypertens 2000; 13: 112S-122S.
9. Palatini P, Benetos A, Grassi G, et al: European Society of Hypertension. Identification and management of the hypertensive patient with elevated heart rate: Statement of a European Society of Hypertension Consensus Meeting. J Hypertens 2006; 24: 603-610.
10. Julius S: Effect of sympathetic overactivity on cardiovasclar prognosis in hypertension. Eur Heart J 1998; 19 (Suppl F): F14-F18.
11. Palatini P, Casiglia E, Pauletto P, Staessen J, Kaciroti N, Julius S: Relationship of tachycardia with high blood pressure and metabolic abnormalities: A study with mixture analysis in three populations. Hypertension 1997; 30: 1267-1273.
12. Grandi AM, Maresca AM, Giudici E, et al: Metabolic syndrome and morphofunctional characteristics of the left ventricle in clinically hypertensive nondiabetic subjects. Am J Hypertens 2006; 19: 199-205.
13. Tomiyama H, Koji Y, Yambe M, et al: Elevated C-reactive protein augments increased arterial stiffness in subjects with the metabolic syndrome. Hypertension 2005; 45: 997-1003.
14. Yambe M, Tomiyama H, Yamada J, et al: Arterial stiffness and progression to hypertension in Japanese male subjects with high normal blood pressure. J Hypertens 2007; 25: 87-93.
15. Yamashina A, Tomiyama H, Takeda K, et al: Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25: 359-364.
16. Tomiyama H, Hashimoto H, Hirayama Y, et al: Synergistic acceleration of arterial stiffening in the presence of raised blood pressure and raised plasma glucose. Hypertension 2006; 47: 180-188.
17. Tomiyama H, Hirayama Y, Hashimoto H, et al: The feects of changes in the metabolic syndrome detection status on arterial stiffnening: A prospective study. Hypertens Res 2006; 29: 673-678.
18. Japan Atherosclerosis Society: Guidelines for Diagnosis and Treatment of Atherosclerotic Cardiovascular Diseases. Tokyo, Life Science Publishing, 2000, pp 4-21 (in Japanese).
19. Japan Diabetes Society: Guidelines for diagnosis of diabetes mellitus. J Jpn Diabetes Soc 1999; 42: 385-404 (in Japanese).
20. Japanese Society of Hypertension: Guidelines for the Management of Hypertension. Tokyo, Life Science Publishing, 2004, pp 14-21 (in Japanese).
21. The Committee of Establishing the Definition of the Diagnosis of Metabolic Syndrome in Japan. Nippon Naika Gakkai Zasshi 2005; 94: 188-203 (in Japanese).
22. WHO: PhysicTl status: the use and interpretation of anthropometry, in: Report of a WHO Expert Consultation. WHO Technical Report Series Number 854. Geneva, World Health Organization, 1995.
23. WHO Expert Consultation: Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-163.
24. Grassi G, Esler MD: How to assess sympathetic activity in humans. J Hypertens 1999; 17: 719-734.
25. Zieman SJ, Melenovsky V, Kass DA: Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005; 25: 1-12.
26. Grynberg A, Ziegler D, Rupp H: Sympathoadrenergic over-activity and lipid metabolism. Cardiovasc Drugs Ther 1996; 10 (Suppl 1): 223-230.
27. Mansell PI, Macdonald IA: Underfeeding and the physiological responses to infused epinephrine in lean women. Am J Physiol 1989; 256 (3 Pt 2): R583-R589.
28. Masuo K, Mikami H, Ogihara T, Tuck ML:, Sympathetic nerve hyperactivity precedes hyperinsulinemia and blood pressure elevation in a young, nonobese Japanese population. Am J Hypertens 1997; 10: 77-83.
29. Levy RL, Hillman CI, Stroud WD, White PD: Transient hypertension: its significance in terms of later development of sustained hypertension and cardiovascular-renal diseases. JAMA 1944; 126: 829-833.
30. Davy KP: The global epidemAc of obesity: are we becoming more sympathetic? Curr Hypertens Rep 2004; 6: 241-246.
31. Huggett RJ, Burns J, Mackintosh AF, Mary DA: Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension 2004; 44: 847-852.
32. Grassi G, Dell'Oro R, Quarti-Trevano F, et al: Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia 2005; 48: 1359-1365.
33. Lindgren K, Hagelin E, Hansen N, Lind L: Baroreceptor sensitivity is impaired in elderly subjects with metabolic syndrome and insulin resistance. J Hypertens 2006; 24: 143-150.
34. Haffner S: Diabetes and the metabolic syndrome - when is it best to intervene to prevent? Atheroscler Suppl 2006; 7: 3-10.
35. Ratner R, Goldberg R, Haffner S, et al, Diabetes Prevention Program Research Group: Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. Diabetes Care 2005; 28: 888-894.
36. Foreyt JP: Need for lifestyHe intervention: how to begin. Am J Cardiol 2005; 96 (4A): 11E-14E.
37. Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA: Heart rate and cardiovascular mortality: The Framingham Study. Am Heart J 1987; 113: 1489-1494.
38. Hozawa A, Ohkubo T, Kikuya M, et al: Prognostic value of home heart rate for cardiovascular mortality in the general population: The Ohasama study. Am J Hypertens 2004; 17 (11 Pt 1): 1005-1010.
39. Shamsuzzaman AS, Gersh BJ, Somers VK: Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 2003; 290 1906-1914.
40. Pickering TG, Gerin W, Schwartz AR: What is the white-coat effect and how should it be measured? Blood Press Monit 2002; 7: 293-300.